Hjem › Skizofreni › Georgia
Skizofreni kliniske forsøg i Georgia
29 studier for Skizofreni søger deltagere på steder i Georgia.
Byer i Georgia
Officiel studietekst (engelsk)
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Decatur
RekruttererFase 4
Alder 12 til 17 · Alle køn · Opdateret 1. okt. 2026 · NCT05648591A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Synexus Clinical Research US Inc, Atlanta
RekruttererFase 1
Alder 18 til 55 · Alle køn · Opdateret 28. sep. 2026 · NCT07615426Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Atlanta Center for Medical Research, Atlanta
- Local Institution - 0070, Sandy Springs
- Local Institution - 0189, Savannah
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 28. sep. 2026 · NCT07686263Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- CenExeli Research LLC, Atlanta
- Atlanta Center for Medical Research, Atlanta
- CenExeli Research LLC 1, Savannah
RekruttererFase 3
Alder 5 til 17 · Alle køn · Opdateret 25. sep. 2026 · NCT06229210NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Decatur
- og 1 flere
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT07227818A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Atlanta Center for Medical Research, Atlanta
- Salveo Integrative Health - Lawrenceville, Lawrenceville
- Denali Health Atlanta, LLC, Stone Mountain
RekruttererFase 3
Alder 5 til 17 · Alle køn · Opdateret 22. sep. 2026 · NCT07424404A Study of Brenipatide in Adult Participants With Schizophrenia
- Atlanta Center for Medical Research, Atlanta
- Augusta University, Augusta
RekruttererFase 2
Alder 18 til 55 · Alle køn · Opdateret 22. sep. 2026 · NCT07410507A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Augusta
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- CenExel iResearch, LLC, Decatur
RekruttererFase 1
Alder 18 til 55 · Alle køn · Opdateret 17. sep. 2026 · NCT0773449352-week Open Label Safety-Tolerability Study
- CenExel, Atlanta
- Accelerated Clinical Trial, Snellville
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 9. sep. 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Atlanta Center for Medical Research, Atlanta
- Salveo Integrative Health - Lawrenceville, Lawrenceville
- Denali Health Atlanta, LLC, Stone Mountain
RekruttererFase 3
Alder 13 til 17 · Alle køn · Opdateret 4. sep. 2026 · NCT07288567A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Atlanta Center for Medical Research, Atlanta
- CenExel iResearch, LLC, Decatur
RekruttererFase 1
Alder 18 til 55 · Alle køn · Opdateret 2. sep. 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Atlanta
- Clinical Site, Decatur
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 1. sep. 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Emory University., Atlanta
- Local Institution - 0049, Austell
- Local Institution - 0044, Marietta
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Decatur
RekruttererFase 3
Alder 10 til 17 · Alle køn · Opdateret 14. aug. 2026 · NCT05303064Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- Bioxcel Clinical Research Site, Decatur
RekruttererFase 1
Alder 10 til 17 · Alle køn · Opdateret 11. aug. 2026 · NCT05025605Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- CenExel iResearch, Decatur
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 29. jul. 2026 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Accelerated Clinical Trial, Snellville
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 27. jul. 2026 · NCT07363577A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Cenexel ACMR, Atlanta
- Cenexel iResearch Atlanta, Decatur
RekruttererFase 2
Alder 18 til 55 · Alle køn · Opdateret 23. jun. 2026 · NCT07191483Anti-Inflammatory Challenge in Schizophrenia
- Grady Memorial Hospital, Atlanta
- Emory University Hospital, Atlanta
RekruttererFase 4
Alder 18 til 55 · Alle køn · Opdateret 3. jun. 2026 · NCT05823532CLOZAPINE Response in Biotype-1
- University of Georgia, Athens
RekruttererFase 4
Alder 18 til 60 · Alle køn · Opdateret 11. maj 2026 · NCT04580134Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- Augusta University Research Institute, Inc., Augusta
RekruttererFase 4
Alder 18 til 65 · Alle køn · Opdateret 4. maj 2026 · NCT05208190Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Georgia, Athens
RekruttererObservationsstudie
Alder 18 til 40 · Alle køn · Opdateret 10. mar. 2026 · NCT06740383NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Atlanta
- Neurocrine Clinical Site, Decatur
- Neurocrine Clinical Site, Snellville
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 6. mar. 2026 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Atlanta
- Vanda Investigational Site, Peachtree Corners
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 12. jan. 2026 · NCT06961968Study of ALTO-101 in Patients With Schizophrenia
- Site 5064, Snellville
RekruttererFase 2
Alder 21 til 55 · Alle køn · Opdateret 26. dec. 2025 · NCT06502964Cognitive Training for Emotion Regulation in Psychotic Disorders
- University of Georgia, Athens
Rekrutterer
Alder 18 til 60 · Alle køn · Opdateret 5. feb. 2025 · NCT04414215Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Atlanta
- Reviva site, Decatur
RekruttererFase 3Frivillige med god helbredstilstand velkomne
Alder 18 til 65 · Alle køn · Opdateret 19. dec. 2024 · NCT05184335Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.